TEVA logo

TEVA EBIT

annual EBIT:

-$369.00M-$774.00M(-191.11%)
December 31, 2024

Summary

  • As of today (June 22, 2025), TEVA annual earnings before interest & taxes is -$369.00 million, with the most recent change of -$774.00 million (-191.11%) on December 31, 2024.
  • During the last 3 years, TEVA annual EBIT has fallen by -$1.92 billion (-123.82%).
  • TEVA annual EBIT is now -109.37% below its all-time high of $3.94 billion, reached on December 31, 2014.

Performance

TEVA EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

quarterly EBIT:

$519.00M+$527.00M(+6587.50%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TEVA quarterly earnings before interest & taxes is $519.00 million, with the most recent change of +$527.00 million (+6587.50%) on March 31, 2025.
  • Over the past year, TEVA quarterly EBIT has increased by +$736.00 million (+339.17%).
  • TEVA quarterly EBIT is now -65.97% below its all-time high of $1.52 billion, reached on March 31, 2018.

Performance

TEVA quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

TTM EBIT:

$454.00M+$736.00M(+260.99%)
March 31, 2025

Summary

  • As of today (June 22, 2025), TEVA TTM earnings before interest & taxes is $454.00 million, with the most recent change of +$736.00 million (+260.99%) on March 31, 2025.
  • Over the past year, TEVA TTM EBIT has increased by +$254.00 million (+127.00%).
  • TEVA TTM EBIT is now -88.47% below its all-time high of $3.94 billion, reached on December 31, 2014.

Performance

TEVA TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

TEVA EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-191.1%+339.2%+127.0%
3 y3 years-123.8%+172.8%+12.7%
5 y5 years+16.7%+171.7%+217.6%

TEVA EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-123.8%+83.5%-28.7%+152.4%-46.6%+120.3%
5 y5-year-123.8%+89.5%-28.7%+112.0%-78.5%+111.8%
alltimeall time-109.4%+97.9%-66.0%+104.0%-88.5%+102.6%

TEVA EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
$519.00M(-6587.5%)
$454.00M(-261.0%)
Dec 2024
-$369.00M(-191.1%)
-$8.00M(-84.6%)
-$282.00M(-162.1%)
Sep 2024
-
-$52.00M(+940.0%)
$454.00M(-46.6%)
Jun 2024
-
-$5.00M(-97.7%)
$850.00M(+325.0%)
Mar 2024
-
-$217.00M(-129.8%)
$200.00M(-50.6%)
Dec 2023
$405.00M(-118.1%)
$728.00M(+111.6%)
$405.00M(-130.8%)
Sep 2023
-
$344.00M(-152.5%)
-$1.31B(+6.0%)
Jun 2023
-
-$655.00M(+5358.3%)
-$1.24B(-19.2%)
Mar 2023
-
-$12.00M(-98.8%)
-$1.53B(-31.4%)
Dec 2022
-$2.23B(-244.2%)
-$990.00M(-336.8%)
-$2.23B(+67.6%)
Sep 2022
-
$418.00M(-144.0%)
-$1.33B(+18.2%)
Jun 2022
-
-$949.00M(+33.1%)
-$1.13B(-379.9%)
Mar 2022
-
-$713.00M(+701.1%)
$403.00M(-74.0%)
Dec 2021
$1.55B(-144.2%)
-$89.00M(-114.3%)
$1.55B(-26.6%)
Sep 2021
-
$623.00M(+7.0%)
$2.11B(-174.0%)
Jun 2021
-
$582.00M(+34.1%)
-$2.85B(-12.6%)
Mar 2021
-
$434.00M(-8.2%)
-$3.26B(-6.9%)
Dec 2020
-$3.50B(+691.2%)
$473.00M(-110.9%)
-$3.51B(-8.5%)
Sep 2020
-
-$4.34B(-2624.4%)
-$3.83B(-990.9%)
Jun 2020
-
$172.00M(-9.9%)
$430.00M(-211.4%)
Mar 2020
-
$191.00M(+29.1%)
-$386.00M(-12.9%)
Dec 2019
-$443.00M(-73.6%)
$148.00M(-282.7%)
-$443.00M(-88.3%)
Sep 2019
-
-$81.00M(-87.4%)
-$3.79B(+2.6%)
Jun 2019
-
-$644.00M(-580.6%)
-$3.70B(+20.5%)
Mar 2019
-
$134.00M(-104.2%)
-$3.07B(+83.0%)
Dec 2018
-$1.68B(-90.4%)
-$3.20B(<-9900.0%)
-$1.68B(-85.4%)
Sep 2018
-
$16.00M(-214.3%)
-$11.51B(+3.2%)
Jun 2018
-
-$14.00M(-100.9%)
-$11.15B(-33.9%)
Mar 2018
-
$1.52B(-111.7%)
-$16.87B(-3.6%)
Dec 2017
-$17.50B(-1377.7%)
-$13.04B(-3548.9%)
-$17.50B(+224.9%)
Sep 2017
-
$378.00M(-106.6%)
-$5.39B(+7.7%)
Jun 2017
-
-$5.74B(-741.3%)
-$5.00B(-554.6%)
Mar 2017
-
$895.00M(-197.2%)
$1.10B(-19.7%)
Dec 2016
$1.37B(-47.7%)
-$921.00M(-220.4%)
$1.37B(-45.0%)
Sep 2016
-
$765.00M(+111.9%)
$2.49B(-9.0%)
Jun 2016
-
$361.00M(-69.0%)
$2.74B(-9.9%)
Mar 2016
-
$1.17B(+479.6%)
$3.04B(+15.9%)
Dec 2015
$2.62B(-33.4%)
$201.00M(-80.1%)
$2.62B(-21.7%)
Sep 2015
-
$1.01B(+52.6%)
$3.35B(-3.0%)
Jun 2015
-
$662.00M(-11.6%)
$3.45B(-7.1%)
Mar 2015
-
$749.00M(-19.4%)
$3.71B(-5.7%)
Dec 2014
$3.94B(+151.8%)
$929.00M(-16.5%)
$3.94B(+13.0%)
Sep 2014
-
$1.11B(+20.2%)
$3.48B(+9.8%)
Jun 2014
-
$925.00M(-4.8%)
$3.17B(+90.9%)
Mar 2014
-
$972.00M(+104.6%)
$1.66B(+6.3%)
Dec 2013
$1.56B(-28.1%)
$475.00M(-40.7%)
$1.56B(+12.7%)
Sep 2013
-
$801.00M(-236.7%)
$1.39B(+163.4%)
Jun 2013
-
-$586.00M(-167.0%)
$527.00M(-75.1%)
Mar 2013
-
$874.00M(+192.3%)
$2.12B(-2.5%)
Dec 2012
$2.17B(-31.8%)
$299.00M(-598.3%)
$2.17B(-15.3%)
Sep 2012
-
-$60.00M(-106.0%)
$2.57B(-29.9%)
Jun 2012
-
$1.01B(+8.5%)
$3.66B(+3.9%)
Mar 2012
-
$928.00M(+34.3%)
$3.52B(+1.8%)
Dec 2011
$3.19B(-17.1%)
$691.00M(-33.2%)
$3.46B(-1.7%)
Sep 2011
-
$1.03B(+19.1%)
$3.52B(-4.2%)
Jun 2011
-
$869.00M(+0.2%)
$3.67B(-5.3%)
Mar 2011
-
$867.00M(+15.4%)
$3.88B(+0.9%)
Dec 2010
$3.85B(+60.0%)
$751.00M(-36.8%)
$3.85B(+9.7%)
Sep 2010
-
$1.19B(+10.5%)
$3.51B(+14.2%)
Jun 2010
-
$1.07B(+28.9%)
$3.07B(+13.8%)
Mar 2010
-
$834.00M(+102.4%)
$2.70B(+12.3%)
Dec 2009
$2.40B(+110.0%)
$412.00M(-45.3%)
$2.40B(+105.4%)
Sep 2009
-
$753.00M(+7.3%)
$1.17B(+9.6%)
Jun 2009
-
$702.00M(+30.5%)
$1.07B(+6.4%)
Mar 2009
-
$538.00M(-165.5%)
$1.00B(-12.3%)
Dec 2008
$1.15B(-52.2%)
-$822.00M(-226.5%)
$1.15B(-56.4%)
Sep 2008
-
$650.00M(+1.9%)
$2.63B(-0.0%)
Jun 2008
-
$638.00M(-6.0%)
$2.63B(+0.0%)
Mar 2008
-
$679.00M(+2.7%)
$2.63B(+9.7%)
Dec 2007
$2.40B(+14.3%)
$661.00M(+1.5%)
$2.40B(+11.0%)
Sep 2007
-
$651.00M(+2.2%)
$2.16B(-3.3%)
Jun 2007
-
$637.00M(+42.8%)
$2.23B(-1.7%)
Mar 2007
-
$446.00M(+5.5%)
$2.27B(+6.6%)
Dec 2006
$2.10B(+59.8%)
$422.80M(-41.6%)
$2.13B(+3.0%)
Sep 2006
-
$723.60M(+7.2%)
$2.07B(+24.9%)
Jun 2006
-
$675.20M(+120.7%)
$1.65B(+28.5%)
Mar 2006
-
$306.00M(-15.1%)
$1.29B(-1.9%)
Dec 2005
$1.31B
$360.30M(+15.4%)
$1.31B(+1.9%)
Sep 2005
-
$312.20M(+1.2%)
$1.29B(-0.4%)
DateAnnualQuarterlyTTM
Jun 2005
-
$308.60M(-6.7%)
$1.29B(+0.9%)
Mar 2005
-
$330.90M(-1.5%)
$1.28B(+9.1%)
Dec 2004
$1.18B(+32.8%)
$336.00M(+5.8%)
$1.18B(+10.3%)
Sep 2004
-
$317.70M(+6.9%)
$1.07B(+12.8%)
Jun 2004
-
$297.10M(+32.5%)
$944.90M(+1.6%)
Mar 2004
-
$224.20M(-1.0%)
$929.70M(+5.1%)
Dec 2003
$884.80M(+68.9%)
$226.50M(+14.9%)
$884.80M(+5.2%)
Sep 2003
-
$197.10M(-30.1%)
$840.90M(+9.9%)
Jun 2003
-
$281.90M(+57.2%)
$765.40M(+28.6%)
Mar 2003
-
$179.30M(-1.8%)
$595.10M(+13.6%)
Dec 2002
$524.00M(+39.2%)
$182.60M(+50.2%)
$524.00M(+15.6%)
Sep 2002
-
$121.60M(+9.0%)
$453.16M(+5.2%)
Jun 2002
-
$111.60M(+3.1%)
$430.56M(+6.1%)
Mar 2002
-
$108.20M(-3.2%)
$405.81M(+7.8%)
Dec 2001
$376.46M(+0.3%)
$111.76M(+12.9%)
$376.51M(-14.6%)
Sep 2001
-
$99.00M(+14.0%)
$440.71M(+5.9%)
Jun 2001
-
$86.85M(+10.1%)
$416.13M(+4.5%)
Mar 2001
-
$78.90M(-55.2%)
$398.12M(+6.1%)
Dec 2000
$375.21M(+40.3%)
$175.95M(+136.4%)
$375.21M(+13.9%)
Sep 2000
-
$74.42M(+8.1%)
$329.32M(+7.4%)
Jun 2000
-
$68.84M(+22.9%)
$306.55M(+8.5%)
Mar 2000
-
$56.00M(-56.9%)
$282.45M(+5.6%)
Dec 1999
$267.47M(+31.3%)
$130.07M(+151.9%)
$267.37M(+10.5%)
Sep 1999
-
$51.64M(+15.4%)
$241.94M(+5.2%)
Jun 1999
-
$44.74M(+9.3%)
$229.99M(+10.1%)
Mar 1999
-
$40.92M(-60.9%)
$208.85M(+2.6%)
Dec 1998
$203.73M(+17.2%)
$104.63M(+163.6%)
$203.53M(-136.9%)
Sep 1998
-
$39.70M(+68.2%)
-$552.30M(+80.9%)
Jun 1998
-
$23.60M(-33.7%)
-$305.30M(+424.5%)
Mar 1998
-
$35.60M(-105.5%)
-$58.20M(-133.5%)
Dec 1997
$173.80M(+34.4%)
-$651.20M(-327.1%)
$173.80M(-37.5%)
Sep 1997
-
$286.70M(+5.9%)
$278.20M(+22.0%)
Jun 1997
-
$270.70M(+1.2%)
$228.10M(+9.9%)
Mar 1997
-
$267.60M(-148.9%)
$207.60M(+60.6%)
Dec 1996
$129.30M(+24.1%)
-$546.80M(-331.1%)
$129.30M(-57.7%)
Sep 1996
-
$236.60M(-5.4%)
$305.50M(+30.4%)
Jun 1996
-
$250.20M(+32.2%)
$234.20M(+66.3%)
Mar 1996
-
$189.30M(-151.1%)
$140.80M(+35.1%)
Dec 1995
$104.20M(+0.7%)
-$370.60M(-324.2%)
$104.20M(-31.1%)
Sep 1995
-
$165.30M(+5.4%)
$151.20M(+16.8%)
Jun 1995
-
$156.80M(+2.7%)
$129.40M(+8.3%)
Mar 1995
-
$152.70M(-147.2%)
$119.50M(+15.5%)
Dec 1994
$103.50M(+17.6%)
-$323.60M(-325.5%)
$103.50M(-28.3%)
Sep 1994
-
$143.50M(-2.3%)
$144.40M(+12.7%)
Jun 1994
-
$146.90M(+7.5%)
$128.10M(+20.6%)
Mar 1994
-
$136.70M(-148.4%)
$106.20M(+20.8%)
Dec 1993
$88.00M(+60.9%)
-$282.70M(-322.2%)
$87.90M(-41.6%)
Sep 1993
-
$127.20M(+1.8%)
$150.50M(+29.4%)
Jun 1993
-
$125.00M(+5.6%)
$116.30M(+38.0%)
Mar 1993
-
$118.40M(-153.8%)
$84.30M(+43.4%)
Dec 1992
$54.70M(+5.0%)
-$220.10M(-336.7%)
$58.80M(-32.1%)
Sep 1992
-
$93.00M(0.0%)
$86.60M(+19.8%)
Jun 1992
-
$93.00M(+0.1%)
$72.30M(+26.6%)
Mar 1992
-
$92.90M(-148.3%)
$57.10M(+10.9%)
Dec 1991
$52.10M(+29.3%)
-$192.30M(-344.3%)
$51.50M(-45.8%)
Sep 1991
-
$78.70M(+1.2%)
$95.00M(+20.4%)
Jun 1991
-
$77.80M(-10.9%)
$78.90M(+11.6%)
Mar 1991
-
$87.30M(-158.7%)
$70.70M(+44.0%)
Dec 1990
$40.30M(-8.8%)
-$148.80M(-337.7%)
$49.10M(+6.0%)
Sep 1990
-
$62.60M(-10.1%)
$46.30M(-2.5%)
Jun 1990
-
$69.60M(+5.9%)
$47.50M(+1.7%)
Mar 1990
-
$65.70M(-143.3%)
$46.70M(-5.1%)
Dec 1989
$44.20M(+96.4%)
-$151.60M(-337.6%)
$49.20M(-37.4%)
Sep 1989
-
$63.80M(-7.3%)
$78.60M(+28.0%)
Jun 1989
-
$68.80M(+0.9%)
$61.40M(+43.8%)
Mar 1989
-
$68.20M(-155.8%)
$42.70M(+74.3%)
Dec 1988
$22.50M(+16.6%)
-$122.20M(-362.2%)
$24.50M(-83.3%)
Sep 1988
-
$46.60M(-7.0%)
$146.70M(+14.1%)
Jun 1988
-
$50.10M(+0.2%)
$128.60M(+22.6%)
Mar 1988
-
$50.00M(+75.4%)
$104.90M(+2284.1%)
Sep 1987
-
$28.50M(+8.0%)
$4.40M(-59.3%)
Jun 1987
-
$26.40M(-130.9%)
$10.80M(-44.0%)
Mar 1987
$19.30M(+62.2%)
-$85.40M(-344.7%)
$19.30M(-60.0%)
Dec 1986
-
$34.90M(0.0%)
$48.20M(+33.5%)
Sep 1986
-
$34.90M(0.0%)
$36.10M(+50.4%)
Jun 1986
-
$34.90M(-161.8%)
$24.00M(+101.7%)
Mar 1986
$11.90M
-$56.50M(-347.8%)
$11.90M(-82.6%)
Dec 1985
-
$22.80M(0.0%)
$68.40M(+50.0%)
Sep 1985
-
$22.80M(0.0%)
$45.60M(+100.0%)
Jun 1985
-
$22.80M
$22.80M

FAQ

  • What is Teva Pharmaceutical Industries Limited annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual EBIT year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly EBIT year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM EBIT year-on-year change?

What is Teva Pharmaceutical Industries Limited annual earnings before interest & taxes?

The current annual EBIT of TEVA is -$369.00M

What is the all time high annual EBIT for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual earnings before interest & taxes is $3.94B

What is Teva Pharmaceutical Industries Limited annual EBIT year-on-year change?

Over the past year, TEVA annual earnings before interest & taxes has changed by -$774.00M (-191.11%)

What is Teva Pharmaceutical Industries Limited quarterly earnings before interest & taxes?

The current quarterly EBIT of TEVA is $519.00M

What is the all time high quarterly EBIT for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly earnings before interest & taxes is $1.52B

What is Teva Pharmaceutical Industries Limited quarterly EBIT year-on-year change?

Over the past year, TEVA quarterly earnings before interest & taxes has changed by +$736.00M (+339.17%)

What is Teva Pharmaceutical Industries Limited TTM earnings before interest & taxes?

The current TTM EBIT of TEVA is $454.00M

What is the all time high TTM EBIT for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM earnings before interest & taxes is $3.94B

What is Teva Pharmaceutical Industries Limited TTM EBIT year-on-year change?

Over the past year, TEVA TTM earnings before interest & taxes has changed by +$254.00M (+127.00%)
On this page